1-(((6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl)-6,7-dihydro-5h-cyclopenta[b]pyridin-1-ium hydrogensulfate
| Title | Journal |
|---|---|
| BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems. | Journal of pharmacokinetics and pharmacodynamics 20120201 |
| False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins. | The Journal of antimicrobial chemotherapy 20110901 |
| Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams. | Critical care (London, England) 20110101 |
| Tigecycline resistance in Serratia marcescens associated with up-regulation of the SdeXY-HasF efflux system also active against ciprofloxacin and cefpirome. | The Journal of antimicrobial chemotherapy 20100301 |
| Microemulsion and mixed micelle for oral administration as new drug formulations for highly hydrophilic drugs. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20100201 |
| Development of an analytical method for cefpirome in plasma by simplified HPLC technique and its applications. | Arzneimittel-Forschung 20100101 |
| Daptomycin elimination by CVVH in vitro: evaluation of factors influencing sieving and membrane adsorption. | International journal of clinical pharmacology and therapeutics 20090301 |
| Emergence of a cefepime- and cefpirome-resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC beta-lactamase, CMY-37. | International journal of antimicrobial agents 20080901 |
| In vitro activity of cefadroxil, cephalexin, cefatrizine and cefpirome in presence of essential and trace elements. | Pakistan journal of pharmaceutical sciences 20071001 |
| Population pharmacokinetics and pharmacodynamics of cefpirome in critically ill patients against Gram-negative bacteria. | Intensive care medicine 20070501 |
| Disposition kinetics and urinary excretion of cefpirome after intravenous injection in buffalo calves. | Journal of veterinary science 20070301 |
| Cefpirome susceptibility in staphylococci isolates. | Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20070101 |
| Application of the ion pair concept to the n-octanol-water partitioning of cefepime and cefpirome. | International journal of pharmaceutics 20060619 |
| [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution]. | The Japanese journal of antibiotics 20060601 |
| Influence of absorption enhancers on the pharmacokinetic properties of non-oral beta-lactam-cefpirom using the rabbit (Chinchilla) in vivo model. | International journal of pharmaceutics 20060217 |
| [High effectiveness of the method with cefpirome in detection of extended-spectrum beta-lactamases in different species of gram-negative bacilli]. | Medycyna doswiadczalna i mikrobiologia 20060101 |
| Susceptibility of Klebsiella spp. to cefpirome and cefepime. | Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20060101 |
| [Application of four variants of the diagnostic disc test (CD01, CD02, CD03, CD04) for detection of ESBL-positive strains of gram-negative rods]. | Medycyna doswiadczalna i mikrobiologia 20050101 |
| In vitro activity of cefepime and cefpirome compared to other third-generation cephem antibiotics against gram-negative nosocomial pathogens. | Die Pharmazie 20041101 |
| Resistance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenes. | Biochemical and biophysical research communications 20040507 |
| Effect of norepinephrine on cefpirome tissue concentrations in healthy subjects. | The Journal of antimicrobial chemotherapy 20040301 |
| In vitro combined bactericidal activity of cefpirome and glycopeptides against glycopeptides and oxacillin-resistant staphylococci. | International journal of antimicrobial agents 20040301 |
| [The trend and susceptibility to antibacterial agents of enterococcus species from urinary tract infections]. | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20040101 |
| In-vitro and in-vivo studies of cefpirom using bile salts as absorption enhancers. | The Journal of pharmacy and pharmacology 20031201 |
| Cefepime versus cefpirome: the importance of creatinine clearance. | Anesthesia and analgesia 20031001 |
| Post-exposure effects of cefepime and cefpirome on isogenic Escherichia coli hosts producing SHV-extended-spectrum beta-lactamases. | Journal of chemotherapy (Florence, Italy) 20030801 |
| [Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2001--II. Gram-negative bacteria]. | The Japanese journal of antibiotics 20030801 |
| Target site bacterial killing of cefpirome and fosfomycin in critically ill patients. | International journal of antimicrobial agents 20030601 |
| Determination of the dissociation constants of the cephalosporins cefepime and cefpirome using UV spectrometry and pH potentiometry. | Journal of pharmaceutical and biomedical analysis 20030410 |
| [Pharmacokinetics of antibiotics in inflamed and healthy lung tissue]. | Wiener medizinische Wochenschrift (1946) 20030101 |
| [Activity of fourth generation cephalosporins against clinical isolates of Enterobacteriaceae]. | Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20030101 |
| Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics. | Oral microbiology and immunology 20021001 |
| Cefpirome sulphate for gynaecological infections and prophylaxis of non-laparotomy surgery in patients with benign disease. | International journal of antimicrobial agents 20020501 |
| [Importance of a cefpirome-vancomycin combination on bactericidal kinetics in severe MRSA infections in intensive care]. | Pathologie-biologie 20020401 |
| Effect of inoculum size on the antibacterial activity of cefpirome and cefepime against Klebsiella pneumoniae strains producing SHV extended-spectrum beta-lactamases. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20011101 |
| A randomized prospective multicentre trial of cefpirome versus piperacillin-tazobactam in febrile neutropenia. | Leukemia & lymphoma 20010701 |
| In vitro activity of cefpirome and vancomycin in combination against gentamicin-susceptible and gentamicin-resistant Staphylococcus aureus. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010401 |
| Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate. | FEMS microbiology letters 20010220 |
| Low cefpirome levels during twice daily dosing in critically ill septic patients: pharmacokinetic modelling calls for more frequent dosing. | Intensive care medicine 20010201 |